FR2347359A1 - Derives de trialcoxybenzylpiperazine n-substituee et leurs utilisations pharmaceutiques, notamment pour leur action vasodilatatrice - Google Patents

Derives de trialcoxybenzylpiperazine n-substituee et leurs utilisations pharmaceutiques, notamment pour leur action vasodilatatrice

Info

Publication number
FR2347359A1
FR2347359A1 FR7710859A FR7710859A FR2347359A1 FR 2347359 A1 FR2347359 A1 FR 2347359A1 FR 7710859 A FR7710859 A FR 7710859A FR 7710859 A FR7710859 A FR 7710859A FR 2347359 A1 FR2347359 A1 FR 2347359A1
Authority
FR
France
Prior art keywords
trialcoxybenzylpiperazine
derivatives
substituted
pharmaceutical uses
vasodilator action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7710859A
Other languages
English (en)
Other versions
FR2347359B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP51040782A external-priority patent/JPS5946227B2/ja
Priority claimed from JP51040783A external-priority patent/JPS5914031B2/ja
Priority claimed from JP51040784A external-priority patent/JPS5914032B2/ja
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of FR2347359A1 publication Critical patent/FR2347359A1/fr
Application granted granted Critical
Publication of FR2347359B1 publication Critical patent/FR2347359B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7710859A 1976-04-09 1977-04-08 Derives de trialcoxybenzylpiperazine n-substituee et leurs utilisations pharmaceutiques, notamment pour leur action vasodilatatrice Granted FR2347359A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP51040782A JPS5946227B2 (ja) 1976-04-09 1976-04-09 Ｎ−置換トリメトキシベンジルピペラジン誘導体
JP51040783A JPS5914031B2 (ja) 1976-04-09 1976-04-09 トリメトキシベンジルピペラジノエタノ−ル誘導体
JP51040784A JPS5914032B2 (ja) 1976-04-09 1976-04-09 ビストリメトキシベンジルピペラジノアルカン類

Publications (2)

Publication Number Publication Date
FR2347359A1 true FR2347359A1 (fr) 1977-11-04
FR2347359B1 FR2347359B1 (fr) 1980-03-28

Family

ID=27290601

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7710859A Granted FR2347359A1 (fr) 1976-04-09 1977-04-08 Derives de trialcoxybenzylpiperazine n-substituee et leurs utilisations pharmaceutiques, notamment pour leur action vasodilatatrice

Country Status (4)

Country Link
US (1) US4100285A (fr)
DE (1) DE2714996A1 (fr)
FR (1) FR2347359A1 (fr)
GB (1) GB1565431A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144991A2 (fr) * 1983-12-10 1985-06-19 Wako Pure Chemical Industries, Ltd. Dérivés de polyméthoxybenzyl pipérazine, procédé pour leur préparation et compositions pharmaceutiques contenant ces dérivés
FR2681324A1 (fr) * 1991-09-18 1993-03-19 Adir Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2934450C2 (de) * 1979-08-25 1984-09-06 Merz + Co GmbH & Co, 6000 Frankfurt N-(Trimethoxybenzyl)-piperazinderivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
DE2934488C2 (de) * 1979-08-25 1984-07-26 Merz + Co GmbH & Co, 6000 Frankfurt N-(Trimethoxybenzyl)-N'-(einfachsubstituierte-phenyl)-piperazine, deren Salze, Verfahren zu deren Herstellung und Arzneimittel
CH643549A5 (de) 1979-08-25 1984-06-15 Merz & Co N-(trimethoxybenzyl)-n'-phenylpiperazine.
US4725597A (en) * 1983-03-21 1988-02-16 Boehringer Ingelheim Ltd. Bis(piperazinyl or homopiperazinyl)alkanes
AU646926B2 (en) * 1991-03-20 1994-03-10 Duphar International Research B.V. Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
CA3068254A1 (fr) 2017-06-20 2018-12-27 Imbria Pharmaceuticals, Inc. Compositions et procedes pour augmenter l'efficacite du metabolisme cardiaque
EP3866794A4 (fr) * 2018-10-17 2022-07-20 Imbria Pharmaceuticals, Inc. Procédés de traitement de maladies rhumatismales à l'aide de composés à base de trimétazidine
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11730733B2 (en) 2020-12-10 2023-08-22 Imbria Pharmaceuticals, Inc. Methods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidine
US11793807B2 (en) 2020-12-10 2023-10-24 Imbria Pharmaceuticals, Inc. Methods of treating heart failure with preserved ejection fraction using modified forms of trimetazidine
US11969422B2 (en) * 2020-12-10 2024-04-30 Imbria Pharmaceuticals, Inc. Methods of treating heart failure with reduced ejection fraction using modified forms of trimetazidine
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060613A (en) * 1976-05-19 1977-11-29 Ayerst Mckenna And Harrison Ltd. 3-Aryloxy-2(4-loweralkyl-1-piperazinyl)propanols, their alkylethers, and use thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0144991A2 (fr) * 1983-12-10 1985-06-19 Wako Pure Chemical Industries, Ltd. Dérivés de polyméthoxybenzyl pipérazine, procédé pour leur préparation et compositions pharmaceutiques contenant ces dérivés
EP0144991A3 (en) * 1983-12-10 1985-07-17 Wako Pure Chemical Industries, Ltd. Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2681324A1 (fr) * 1991-09-18 1993-03-19 Adir Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
EP0533579A1 (fr) * 1991-09-18 1993-03-24 Adir Et Compagnie Nouveaux dérivés de la trimétazidine, leur procédé de préparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2347359B1 (fr) 1980-03-28
DE2714996A1 (de) 1977-10-13
GB1565431A (en) 1980-04-23
US4100285A (en) 1978-07-11

Similar Documents

Publication Publication Date Title
NL7612286A (nl) Piperidinederivaten en werkwijze voor hun be- reiding.
BE847742A (fr) Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques
BE859012A (fr) Derives de 4-n-acylfortimicines b, leur preparation et leur application
FR2336415A1 (fr) Thiopolymeres, et derives de ceux-ci, procedes pour leur preparation, et leur application.
FR2347359A1 (fr) Derives de trialcoxybenzylpiperazine n-substituee et leurs utilisations pharmaceutiques, notamment pour leur action vasodilatatrice
NL7613660A (nl) N2-arylsulfonyl-l-argininamiden en de farmaceutisch aanvaardbare zouten ervan.
FR2314967A1 (fr) Machine de bourrage des voies ferrees, notamment machine de bourrage et de nivellement
BE841537A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
FR2342724A1 (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
NL7601762A (nl) Tetralon- en indanonderivaten en werkwijze voor de bereiding hiervan.
NL7608206A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
NL7706622A (nl) Polyenen en werkwijze voor hun bereiding.
FR2330404A1 (fr) Derives de la 1,4-diazepine, leur preparation et leurs utilisations therapeutiques
BE857529A (fr) Fluorosulfonyl-oxafluoralcanes, leurs derives, fluorosulfonylolefines, leurs copolymeres et procedes pour leur preparation
BE859613A (fr) Derives de steroides leur preparation et leurs utilisations therapeutiques
FR2318853A1 (fr) Derives de dodecatetraene, leur preparation et leurs utilisations
BE841536A (fr) Melanges d'aminoalcanols, leur preparation et leurs utilisations
BE857576A (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
BE838779A (fr) Isocyanates heterocycliques, leur preparation et leurs utilisations
MC1344A1 (fr) Derives de la pyrrolidine,leur preparation et leurs utilisations therapeutiques
SE7609908L (sv) 1,5-dihydro-2h-1,4-bensodiazepin-2-on-derivat och framstellning derav
NL7711936A (nl) Ureumderivaten en werkwijze voor de bereiding en toepassing ervan.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7611159A (nl) Thiazolidinederivaten en werkwijze voor hun bereiding.
FR2323382A1 (fr) Derives de 1-oxo-isoindoline, leurs procedes de preparation et leur application

Legal Events

Date Code Title Description
ST Notification of lapse